ELOVL3 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL486146	1.00	6/20
SCHEMBL486176	1.00	6/20
SCHEMBL486252	1.00	6/20
SCHEMBL486337	1.00	6/20
SCHEMBL486547	1.00	6/20
SCHEMBL486551	1.00	6/20
SCHEMBL486608	1.00	6/20
SCHEMBL486655	1.00	6/20
SCHEMBL486051	0.93	6/20
SCHEMBL486441	0.89	6/20
SCHEMBL486548	0.88	6/20
SCHEMBL486064	0.88	6/20
SCHEMBL486253	0.88	6/20
SCHEMBL486256	0.88	6/20
SCHEMBL486406	0.88	6/20
SCHEMBL486026	0.87	6/20
SCHEMBL486391	0.87	6/20
SCHEMBL486132	0.87	6/20
SCHEMBL486223	0.87	6/20
SCHEMBL486069	0.85	6/20

Clinical trials — most relevant to ELOVL3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids	PHASE2/PHASE3	COMPLETED
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders	PHASE3	UNKNOWN
Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)	PHASE2	COMPLETED
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver	PHASE2	COMPLETED
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention	PHASE2	COMPLETED
Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy	PHASE1	COMPLETED
Omega-3 vs Very Low Calorie Diet for Liver Size Reduction	nan	UNKNOWN
The Effects of Milk Protein Versus Soy Protein on Essential Omega-3 Fatty Acid Metabolism	nan	ACTIVE_NOT_RECRUITING
Canola Oil Multicentre Intervention Trial	nan	COMPLETED
Acute Effects of Fats on Satiety and Energy Needs	nan	COMPLETED
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study	nan	COMPLETED
Genotype-related Effects of PUFA	nan	COMPLETED
Sacha Inchi Oil Supplementation in 3Hs	nan	COMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity	nan	COMPLETED
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish)	nan	UNKNOWN
Metabolic Actions of Omega-3 Fatty Acids	nan	COMPLETED
Obesity, Inflammation and Aging: Effects of Physical Exercise and Omega-3 Fatty Acids.	nan	COMPLETED
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing	nan	COMPLETED
Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo	nan	COMPLETED
Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors	nan	ACTIVE_NOT_RECRUITING
Influence of the Background Diet on Metabolism of Land-based n-3 PUFA	nan	COMPLETED
Krill Oil Supplementation: Effects on Breast Milk Composition	nan	COMPLETED
Dietary Intake of Whole Walnuts in Adult Subjects Under Low Cardiovascular Risk	nan	COMPLETED
Adjunct Use of Diode Laser Therapy and Omega 3 Gel in Local Drug Delivery Approach on The Treatment of Localized Aggressive Periodontitis	nan	COMPLETED
Lipid Mediators in Multiple Sclerosis	nan	COMPLETED
Exercise Intolerance Study in Long Chain Fatty Acid Oxidation Disorders	nan	RECRUITING
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents	nan	ACTIVE_NOT_RECRUITING
Omega-3 Fatty Acid Supplementation and Fractional Iron Absorption in Obese South African Women	nan	COMPLETED
Effect of n-3 Polyunsaturated Fatty Acids Supplementation on Human Milk Composition of Lactating Women	nan	COMPLETED
Omega-3 Supplementation Decreases Inflammation and Fetal Obesity in Pregnancy	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a ELOVL3 binder may also engage these)

Protein	Name	Similarity
O35949	—	0.999	O35949 →
Q03574	—	0.996	Q03574 →
Q4D5J7	—	0.995	Q4D5J7 →
Q4DUK4	—	0.995	Q4DUK4 →
Q4DHY3	—	0.992	Q4DHY3 →
Q54TC9	—	0.992	Q54TC9 →
Q9JLJ5	—	0.991	Q9JLJ5 →
G5EEE5	—	0.990	G5EEE5 →
P49191	—	0.990	P49191 →
Q57UP6	—	0.988	Q57UP6 →
Q9XVQ9	—	0.988	Q9XVQ9 →
A0JNC4	—	0.988	A0JNC4 →
D4ADY9	—	0.987	D4ADY9 →
Q4QJ85	—	0.987	Q4QJ85 →
Q20303	—	0.986	Q20303 →
Q9VH58	—	0.986	Q9VH58 →
B4QVX4	—	0.986	B4QVX4 →
ELOVL1	Very long chain fatty acid elongase 1	0.985	landscape →
Q20300	—	0.984	Q20300 →
Q9D2Y9	—	0.984	Q9D2Y9 →
Q4D321	—	0.983	Q4D321 →
Q4DHY2	—	0.983	Q4DHY2 →
Q9VV87	—	0.983	Q9VV87 →
A1L3X0	—	0.982	A1L3X0 →
Q4DUK7	—	0.981	Q4DUK7 →
Q57UP7	—	0.979	Q57UP7 →
Q9NXB9	—	0.979	Q9NXB9 →
Q54CJ4	—	0.977	Q54CJ4 →
Q32NI8	—	0.977	Q32NI8 →
Q57UP8	—	0.977	Q57UP8 →